NeoRestoration Foundation

NeoRestoration Foundation The NeoRestoration Foundation (NRF) is a 501 (c)(3) non-profit organization dedicated to funding advanced neuroscience research.

A team led by HMS stem cell biologists has discovered a way to grow the type of brain cells that degenerate in patients ...
03/02/2026

A team led by HMS stem cell biologists has discovered a way to grow the type of brain cells that degenerate in patients with amyotrophic lateral sclerosis (ALS) and that are damaged in spinal cord injuries.

This image shows a neuron engineered by the Macklis Lab with the cell body extending a long axon.

Working in lab dishes, researchers engineered a cocktail of molecular signals to coax some progenitor cells — precursors that can differentiate into other cell types — to generate corticospinal neurons, brain cells vital to voluntary motor control.

Although further research is needed, the achievement opens new paths for developing regenerative medicine-based treatments for the two devastating neurological afflictions.

Doctors recommended it to women. Now thousands regret it. Here's why...The truth about Depo-Provera and brain tumors wil...
03/02/2026

Doctors recommended it to women. Now thousands regret it. Here's why...

The truth about Depo-Provera and brain tumors will blow your mind.

If you or a loved one developed a brain tumor or meningioma after taking the shot, you're not alone.

There could be between 16,000 and 18,000 cases involving women diagnosed with meningiomas linked to Depo-Provera use.

One study found that 83.2% of women diagnosed with meningioma had been exposed to Depo-Provera.

You may not be the type to sue but you deserve answers.

You weren't warned and now you could be owed.

The First Recorded De@th from an Exploding V**e PenIn 2018, a 38-year-old man from Florida became the first documented c...
03/02/2026

The First Recorded De@th from an Exploding V**e Pen

In 2018, a 38-year-old man from Florida became the first documented case in U.S. history of de@th caused by an exploding v**e pen.

According to investigators, the device’s lithium-ion battery exploded while the man was using it — the force was so powerful that part of the v**e pen shot upward through his face and skull, causing fatal head trauma. The blast also ignited a fire that burned over 80% of his body.

💨 V**es may look harmless, but they rely on unregulated lithium batteries that can overheat, vent, or explode if damaged, modified, or charged improperly.

If you or someone you know v**es, remember:
• Never use off-brand chargers 🔋
• Avoid damaged batteries 🔥
• Don’t carry loose batteries in pockets with keys or coins

Sometimes, the biggest risks don’t come from what’s inside the v***r — but from what’s powering it.

Registration is open for the 49th Annual Barrow Neuroscience Symposium! This three-day conference will bring together gr...
03/02/2026

Registration is open for the 49th Annual Barrow Neuroscience Symposium! This three-day conference will bring together great minds from near and far to advance the knowledge and practice of medicine in neuroscience.

📆: Wednesday, May 13 - Friday, May 15, 2026
📍: In person only at Barrow Neurological Institute, 2910 North Third Avenue, Phoenix, AZ 85013

Register before April 22 to receive an early-bird discount: bar.rw/neurosymposium2026 (link in bio). Stay tuned for this year’s agenda!

(🎨: Dani VanBrabant, Barrow Neuroscience Publications)

03/02/2026

Dr. Tatiana Coelho de Sampaio, a professor at the Federal University of Rio de Janeiro (UFRJ), is making global headlines for her pioneering work in neural regeneration. After nearly 30 years of research, she developed polylaminin, an experimental protein derived from human placentas that acts as a "biological scaffold" to help damaged neurons reconnect.

In a preliminary academic study involving eight patients with acute spinal cord injuries, two did not survive their initial trauma, but the remaining six survivors all showed unprecedented motor recovery. Most notably, one patient, Bruno Drummond de Freitas, regained the ability to walk after being diagnosed with quadriplegia, while others recovered significant trunk control and limb mobility.

The treatment involves a single surgical injection of polylaminin directly into the injured area, ideally within 72 hours of the accident. While some experts urge caution until larger, peer-reviewed clinical trials are completed, the results have been described as a "world first" in successfully regenerating spinal cord tissue in humans.

In February 2026, Dr. Sampaio announced that her manufacturing partner, Cristália Laboratory, has committed to providing the drug for free through the Brazilian public health system (SUS) once it receives final regulatory approval. The discovery has placed Brazil at the forefront of regenerative medicine, with many in the scientific community now mentioning Sampaio as a potential candidate for the Nobel Prize in Medicine.

As Phase 1 human trials begin, the medical world is watching closely to see if this breakthrough can finally offer a standardized cure for conditions previously deemed irreversible.

Join us for the 4th Annual Neuroplastic and Reconstructive Surgery Symposium, hosted by Dr. Netanel Ben-Shalom and the D...
03/02/2026

Join us for the 4th Annual Neuroplastic and Reconstructive Surgery Symposium, hosted by Dr. Netanel Ben-Shalom and the Department of Neurosurgery at Lenox Hill Hospital.

Friday, March 20, 2026 | 7:30am – 4pm

This full-day program is designed for physicians, advanced care providers and students, and will feature lectures on advances in neuroplastic and reconstructive surgery, case-based discussions, hands-on demonstrations and interactive learning with leading experts.

Space is limited and registration is required. Please RSVP by Wednesday, March 18 at 5pm.

For years, Southwest Airlines had a well-known problem. Under its open seating system, whoever boarded first got the bes...
03/02/2026

For years, Southwest Airlines had a well-known problem. Under its open seating system, whoever boarded first got the best seats, and passengers who requested wheelchair assistance were automatically preboarded before everyone else. Flight attendants called them "miracle flights" because dozens of passengers who needed wheelchairs at departure would walk off the plane unaided at arrival.

The scale of the issue was significant. According to iEagle, Southwest's internal data showed that on one flight with just 85 passengers, 28 requested wheelchairs during boarding, but only 2 or 3 needed help deplaning. Some flights reportedly saw over 100 wheelchair requests, and staff estimated more than 80 percent came from passengers who didn't actually need mobility assistance.

Then on January 27, Southwest ended its 50-plus-year open seating policy and switched to assigned seating. The incentive to game the system vanished almost overnight. One frequent flyer told Memphis Today they used to see 5 to 6 wheelchair passengers preboarding every flight but hadn't seen a single one in the past month.

Southwest is still legally required to provide wheelchair assistance to anyone who requests it and cannot ask for proof of disability. Preboarding for passengers with disabilities continues. The only difference is that it no longer comes with first pick of any seat on the plane.

Not all disabilities are visible, and many passengers genuinely need help. But the dramatic drop confirms what flight attendants had been saying for years.

02/14/2026
02/12/2026
02/12/2026
02/12/2026

Address

40 W 57th Street
New York, NY
10019

Website

Alerts

Be the first to know and let us send you an email when NeoRestoration Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NeoRestoration Foundation:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

NeoRestoration Foundation

The NeoRestoration Foundation (NRF) meets a critical need for research, access and recovery in spinal cord injury treatment. Every year, around the world, between 250,000 to 500,000 people suffer a spinal cord injury (SCI). There are about 12,000 new SCIs every year, and the majority of them (82 percent) involve males between the ages of 16-30. These injuries result from motor vehicle accidents (36 percent), violence (28.9 percent) or falls (21.2 percent). A spinal cord injury (SCI) is damage to the spinal cord that causes changes in its function, either temporary or permanent. These changes translate into loss of muscle function, sensation, or autonomic function in parts of the body served by the spinal cord below the level of the lesion.

In early 2000, John Wood McDonald III, MD PhD and his team were the first to report that oligodendrocytes do regenerate when stimulated by exercise. Hence he launched new and innovative protocols known as Restorative Therapy Integration (RTI) in treating patients with spinal cord injury. This lead the way for Dr. McDonald recognizing that the micro repair of the spinal cord to restore and recover function if volitional exercise was employed. This discovery gave birth for him to develop Activity Based Restorative Therapy (ABRT).

In 2004, Dr. McDonald built and became the Executive Director of the International Center for Spinal Cord Injury ICSCI at Kennedy Krieger Institute at Johns Hopkins in Baltimore. It is here that he and his team he brought with him from St. Louis; he further expanded and improved ABRT and pushed for the expansion and improvements in technology and more research to move medical science forward. ABRT is now a therapeutic protocol used worldwide from those who have sustained a spinal cord injury and has been the driving force to expand and rewrite the protocols of treatment of people experiencing other movement disorders. The cross collaboration of world-renowned scientists from different research institutions across the world, lead to further innovations in technology, advances in stem cell treatment and improved pharmacological treatment and a better understanding of the underlying mechanisms to repair and restore muscle mass, movement and neuronal cell regeneration enabling patients to regain independence. Their plan integrates the most advanced knowledge in neuroscience, epigenetics, nanotechnology, molecular biology, electrophysiology, and functional brain imaging. According to Dr. McDonald, today, it is improvements in technology that will be the single most significant factor in moving medical science forward.

NeoRestoration Foundation was founded in 2017 by Ellizzette Duvall McDonald inspired by her brilliant husband, John W. McDonald III MD PhD, who pioneered the research and recovery in spinal cord injury patients through his stem cell research that lead to multiple other discoveries, patents and protocols in the field of neuroscience and neurology. Today his historical groundbreaking work and legacy continues among his collaborators. NRF is headquartered in New York City, with offices in St. Louis. 100% of all donations go directly to research.